Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04601402
Title GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genome & Company

head and neck squamous cell carcinoma

transitional cell carcinoma

lung non-small cell carcinoma

Advanced Solid Tumor


Avelumab + GEN-001

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.